Litcius/Paper detail

Lentinan mitigates pemetrexed chemoresistance by the PI3K/Akt pathway in non-small cell lung cancer

Ping Tian, Dajun Du, Yang Li, Nan Zhou, Ling Tao

2024Cell Biochemistry and Biophysics11 citationsDOI

Topics & Concepts

LentinanPemetrexedPI3K/AKT/mTOR pathwayProtein kinase BCancer researchLung cancerChemistryPharmacologyOxidative stressApoptosisMedicineInternal medicineCisplatinChemotherapyBiochemistryPolysaccharidePI3K/AKT/mTOR signaling in cancerCancer Treatment and PharmacologyFungal Biology and Applications
Lentinan mitigates pemetrexed chemoresistance by the PI3K/Akt pathway in non-small cell lung cancer | Litcius